Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2003
06/26/2003US20030119868 Gyrase inhibitors and uses thereof
06/26/2003US20030119857 Pyrimidinyl methyl indole derivatives with antibacterial activity
06/26/2003US20030119845 4-((4-benzyl(or methyl heteroaryl)-,1-piperazinyl)(8-quinolinyl)methyl)-N,N-diethylbenzamide or salt, useful for pain treatment
06/26/2003US20030119844 Bind with high selectivity and/ or high affinity to CRF1 receptors (Corticotropin Releasing Factor 1 Receptors), useful for treating psychiatric and neurological diseases, including depression, anxiety and post trauma stress
06/26/2003US20030119843 Tricycloheteroaromic ring containing imidazole compounds used as farnesyl transferase and geranylgeranyl transferase inhibitor
06/26/2003US20030119839 Indalones and other fused heterocylce-ones
06/26/2003US20030119836 Cyclooxygenase inhibitors
06/26/2003US20030119835 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119819 Anticancer agents
06/26/2003US20030119810 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
06/26/2003US20030119806 Azetidine derivatives, processes for their preparation and their use as pesticides
06/26/2003US20030119754 Treating respiratory syncytial virus and human parainfluenza virus infections
06/26/2003US20030119749 Novel compounds possessing antibacterial, antifungal or antitumor activity
06/26/2003US20030119670 Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof
06/26/2003US20030119029 Apoptosis, autoimmune diseases, antiproliferative agents, antiinflammatory agents, anticancer agents
06/26/2003CA2470811A1 Protease inhibitors of the coagulation cascade isolated from dysidea sponges
06/26/2003CA2470616A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2003CA2470307A1 Protein kinase inhibitors
06/26/2003CA2470276A1 Substituted phenyl derivatives
06/26/2003CA2470236A1 Lactams as tachykinin antagonists
06/26/2003CA2470214A1 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
06/26/2003CA2470030A1 2-guanidino-4-heterocyclylquinazolines
06/26/2003CA2469305A1 Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
06/26/2003CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1320366A1 Substituted piperidines as melanocortin receptor agonists
06/25/2003EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
06/25/2003EP1064279B1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
06/25/2003EP0966282B1 Use of the angiotensin ii antagonists losartan and exp-3174 to treat symptomatic heart failure
06/25/2003CN1426451A Composition and method for bleaching substrate
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426409A Inhibitors of dipeptidyl peptidase IV
06/25/2003CN1426408A Pyrimidinyl methyl indole derivatives with antibacterial activity
06/25/2003CN1426395A Inhibitors of dipeptidyl peptidase IV
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/25/2003CN1425654A Process for preparing 2-alkoxybenzimidazole compound
06/24/2003US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper
06/24/2003US6583166 Fewer side effects than D2 receptor antagonist neuroleptics; cardiovascular, kidney, central nervous system disorders; 3-(3-((4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl) propyl)-1,3,3a,4,5,9b-hexahydro-2H-benzo(e)indol-2-one
06/24/2003US6583148 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine
06/24/2003US6583090 Hetaryl-substituted benzyl phenyl ethers, method for the production thereof, and their use for combating harmful fungi and animal pests
06/24/2003US6582351 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE
06/24/2003CA2276405C Benzimidazole derivatives and pharmacologically acceptable salts thereof
06/24/2003CA2066094C Fused heterocyclic compounds, their production and use
06/19/2003WO2003050261A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
06/19/2003WO2003050110A1 Amorphous form of 2-n-butyl-3-( (2-(1h-tetrazol-5-yl) (1,1'-biphenyl)-4-yl) methyl) -1,3-diazaspiro (4,4') non-1-en-4-one
06/19/2003WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049678A2 Mitotic kinesin inhibitors
06/19/2003WO2003049542A1 Pyrazoles-pyrimidine fungicides
06/19/2003US20030114683 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors
06/19/2003US20030114668 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
06/19/2003US20030114666 Antibacterial agents
06/19/2003US20030114509 Prophylactic or therapeutic drug for renal diseases
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114472 Viricides
06/19/2003US20030114465 Substituted imidazole neuropeptide Y Y5 receptor antagonists
06/19/2003US20030114463 Tetrahydroindolone and purine derivatives linked to arylpiperazines
06/19/2003US20030114456 Antiinflammatory agents, analgesics, antipyretics
06/19/2003US20030114452 Controlling cell signal transcription, transduction; antiinflammatory agents, rheumatic diseases
06/19/2003US20030114448 Inhibitors of factor Xa
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003US20030114446 Induce immunology response
06/19/2003US20030114445 Bactericides
06/19/2003US20030114425 Tiamenidine
06/19/2003US20030113643 Electrophotographic organophotoreceptors with novel charge transport materials
06/19/2003US20030113132 Charge transport compounds of hydrazone substituted carbazole derivatives, a charge generating compound and electroconductive substrate
06/19/2003CA2469656A1 Amorphous form of 2-n-butyl-3-( (2-(1h-tetrazol-5-yl) (1,1'-biphenyl)-4-yl) methyl) -1,3-diazaspiro (4,4') non-1-en-4-one
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2468266A1 Substituted bicyclic pyrimidinones as a mitotic kinesin ksp inhibitors
06/19/2003CA2460122A1 Pyrazoles-pyrimidine fungicides
06/18/2003EP1319047A1 Cyanine dyes
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318996A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318984A1 4-amino-quinazolines
06/18/2003EP1318983A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1115704B1 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes
06/18/2003EP1082297B1 Substituted dithio-bis-nitrobenzenes and their applications
06/18/2003EP0757677B1 Benzocyclohexylimidazolethione derivatives
06/18/2003CN1425008A 3-aminoquinazolin-2, 4-dione antibacterial agents
06/18/2003CN1425003A Methylation of indole compounds from dimethyl carbonate
06/18/2003CN1425002A Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders
06/18/2003CN1111530C Process for preparing compounds of dipyrimidine salicylate
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111528C Piperazino derivatives as neurokinin antagonists
06/17/2003US6579983 5-cyano-2-aminopyrimidine derivatives
06/17/2003US6579894 Bactericides, fungicides
06/17/2003US6579892 Affective disorders; neurotic, stress and somatoform disorders and psychoses, e.g. schizophrenia 3-(3-(6-Methyl-1,2,3,4-tetrahydronaphth-2-ylamino)propylmercap to) -4-methyl-5-phenyl-1,2,4(4H)-triazole
06/17/2003US6579881 Muscle relaxants, antiserotonine agent
06/17/2003US6579879 For therapy of diabetic neuropathy, diabetic retinopathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic microangiopathy and diabetic macroangiopathy in mammals
06/17/2003US6579874 Substituted azoles
06/17/2003US6579873 Treatment of inflammation, arthritis, bone disorders, respiratory system disorders
06/12/2003WO2003048156A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
06/12/2003WO2003048135A1 Amorphous and crystalline forms of losartan potassium and process for their preparation
06/12/2003WO2003048133A1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
06/12/2003WO2003048130A2 Peroxisome proliferator activated receptor agonists
1 ... 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 ... 626